tiprankstipranks
Trending News
More News >
Plus Therapeutics (PSTV)
:PSTV
US Market

Plus Therapeutics (PSTV) Income Statement

Compare
1,567 Followers

Plus Therapeutics Income Statement

Last quarter (Q3 2025), Plus Therapeutics's total revenue was $1.40M, a decrease of -4.05% from the same quarter last year. In Q3, Plus Therapeutics's net income was $-4.42M. See Plus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.82M$ 4.91M$ 224.00K$ 0.00$ 303.00K
Gross Profit
$ 4.97M$ -4.78M$ -488.00K$ -66.00K$ -2.40M
Operating Expenses
$ 19.67M$ 8.54M$ 19.22M$ 12.43M$ 7.19M
Depreciation and Amortization
$ 852.00K$ 628.00K$ 712.00K$ 419.00K$ 366.00K
EBITDA
$ -8.40M$ -12.69M$ -18.85M$ -12.05M$ -8.44M
Operating Income
$ -14.70M$ -13.32M$ -19.71M$ -12.49M$ -9.58M
Other Income/Expenses
$ 1.72M$ 5.00K$ -563.00K$ -907.00K$ 1.34M
Pretax Income
$ -12.98M$ -13.32M$ -20.27M$ -13.40M$ -8.24M
Net Income
$ -12.98M$ -13.32M$ -20.27M$ -13.40M$ -8.24M
Per Share Metrics
Basic EPS
$ -1.95$ -4.24$ -11.55$ -17.78$ -27.90
Diluted EPS
$ -2.34$ -4.24$ -11.55$ -17.78$ -27.90
Weighted Average Shares Outstanding
6.64M 3.14M 1.75M 804.74K 295.19K
Weighted Average Shares Outstanding (Diluted)
7.70M 3.14M 1.75M 805.95K 295.19K
Currency in USD

Plus Therapeutics Earnings and Revenue History